DoD Lung Cancer Research Program Investigator-Initiated Translational Research Award

The summary for the DoD Lung Cancer Research Program Investigator-Initiated Translational Research Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
DoD Lung Cancer Research Program Investigator-Initiated Translational Research Award: The Investigator-Initiated Translational Research Award (IITRA) supports translational research that will develop promising ideas in lung cancer into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. Observations that drive a research idea may originate from a laboratory discovery, population-based studies, or a clinician’s firsthand knowledge of patient care. The ultimate goal of translational research is to move a concept or observation forward into clinical application. However, Principal Investigators (PIs) should not view translational research as a one-way continuum from bench to bedside. The research plan must involve a reciprocal flow of ideas and information between basic and clinical science.
This mechanism is intended to fund a broad range of translational studies, including, but not limited to, the following:
• Studies advancing/translating in vitro and/or animal studies to applications with human samples/cohorts.
• Late-stage preclinical work leading to/preparing for a clinical trial, e.g., Investigational New Drug (IND) application submission.
• Correlative studies that are associated with an ongoing or completed clinical trial and projects that develop endpoints for clinical trials.

Preliminary data to support the feasibility of the research hypotheses and research approaches are required; however, these data do not necessarily need to be derived from studies of lung cancer.
Federal Grant Title: DoD Lung Cancer Research Program Investigator-Initiated Translational Research Award
Federal Agency Name: Dept of the Army USAMRAA
Grant Categories: Science and Technology
Type of Opportunity: Discretionary
Funding Opportunity Number: W81XWH-16-LCRP-IITRA
Type of Funding: Cooperative Agreement, Grant
CFDA Numbers: 320909
CFDA Descriptions: Military Medical Research and Development
Current Application Deadline: Sep 14, 2016
Original Application Deadline: Sep 14, 2016
Posted Date: Apr 11, 2016
Creation Date: Apr 11, 2016
Archive Date: Oct 14, 2016
Total Program Funding: $2,560,000
Maximum Federal Grant Award: none
Minimum Federal Grant Award: none
Expected Number of Awards: 4
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Grant Announcement Contact
CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org
CDMRP Help Desk

Dept. of the Army -- USAMRAA 301-619-7144
More Grants from the Dept of the Army USAMRAA
Department of Defense Congressionally Directed Medical Research Programs PHTBI Applied Beh...
DoD USAMRMC FY18-FY22 Broad Agency Announcement for Extramural Medical Research
DoD Medical Simulation and Information Sciences, Toward A Next-Generation Trauma Care Capa...
DoD Hearing Restoration Research Program Translational Research Award
DoD Hearing Restoration Research Program Focused Research Award

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2017 FederalGrants.com